SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SMS Lifesciences India informs about newspaper advertisements

11 Aug 2022 Evaluate
SMS Lifesciences India has informed that it enclosed copies of the newspaper advertisements published in ‘Financial Express -English’ & ‘Nava Telangana -Telugu’ today August 11, 2022, regarding financial results for the quarter ended June 30, 2022. This was published within 48 hours of the closure of the Board meeting as specified in Regulation 4713) of SEBI Listing Obligations & Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Haleos Labs Share Price

1300.00 1.00 (0.08%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×